Asthma patients were the first to be treated in the halochamber. Observing the patients, we discovered interesting changes in our clinical findings, and we received data from functional and laboratory researches. We gradually expanded and refined the recommended uses and warnings, and studied the effects of dry aerosol salt. We also gradually increased the credibility of the method amongst pulmonologists.
After gaining experience in using halotherapy, we concluded that in order to achieve safe and effective treatment, the concentration of salt aerosol and particle size are of the utmost importance.
After the collapse of the USSR, we continued to develop halotherapy, and in 1992, my colleagues and I created a scientifically substantiated method – controlled halotherapy. We introduced and patented this new method of treating diseases of the respiratory system. It is based on the principle of selection and maintenance of defined salt aerosol concentrations, depending on the characteristics of the disease. As a result of the collaboration with the Aeromed, an engineering company based in St. Petersburg, Russia, we created a fundamentally new generation of halogenerators, which control and provide salt aerosol to the salt rooms in the appropriate amount.
Before our invention, it was impossible to manage and maintain different levels of the concentration of dry salt aerosol in the salt chamber. Our new halogenerators receive feedback from a concentration sensor and a microprocessor, which allows us to establish the necessary concentration of aerosol for our patients and maintain its level throughout the procedure. In order to develop this method of halotherapy, we laboured for 20 years, from covering walls with salt to using halogenerators, which release salt aerosol when necessary in order to maintain the desired conditions.
With the help of leading scientific institutions, we conducted research to substantiate the process and effects of controlled halotherapy. I have summarized the results of these scientific and practical researches in my doctoral dissertation, ‘Haloaerosol Therapy in the Treatment and Prevention of Respiratory Diseases’. As a lecturer for courses of advanced training for doctors, I have the constant opportunity to monitor the experience of using halotherapy and receive new information. This helps to reveal prospective methods for improving the technology for its various applications.